Table 3.

Bivariate analysis for the difference in symptom prevalence and HRQOL between cancer survivors and non-cancer individuals^#

	All cancer survivors† (Recent and long-term)	Recent survivors†	Long-term survivors†	Non-cancer individuals (Reference)†
Sensation abnormality
Prevalence, %	60.99	59.16	62.22	39.28
OR (95% CI)‡	2.42*** (1.92, 3.04)	2.24*** (1.59, 3.16)	2.55*** (1.91, 3.39)	1.00
Pain
Prevalence, %	73.47	71.87	74.56	56.63
OR (95% CI)‡	2.12*** (1.71, 2.64)	1.95*** (1.38, 2.77)	2.24*** (1.72, 2.93)	1.00
Fatigue
Prevalence, %	68.58	69.70	67.84	60.99
OR (95% CI)‡	1.40** (1.11, 1.76)	1.47* (1.03, 2.10)	1.35 (0.99, 1.83)	1.00
Cognitive disturbance
Prevalence, %	32.22	30.24	33.55	21.07
OR (95% CI)‡	1.78*** (1.40, 2.26)	1.62** (1.15, 2.28)	1.89*** (1.41, 2.54)	1.00
Depression
Prevalence, %	43.43	43.09	43.65	41.23
OR (95% CI)‡	1.09 (0.87, 1.37)	1.08 (0.08, 1.50)	1.10 (0.83, 1.46)	1.00
Anxiety
Prevalence, %	62.86	58.82	65.55	59.35
OR (95% CI)‡	1.16 (0.94, 1.44)	0.98 (0.69, 1.39)	1.30* (1.01, 1.69)	1.00
Physical HRQOL
Raw score	49.60	49.31	49.79	53.24
Difference (95% CI)‡	−3.65*** (−4.71, −2.58)	−3.46*** (−4.73, −2.18)	−3.93*** (−5.68, −2.18)	1.00
Mental HRQOL
Raw score	52.76	52.77	52.76	53.85
Difference (95% CI)‡	−1.09 (−2.19, 0.02)	−1.09 (−2.49, 0.31)	−1.09 (−2.57, 0.40)	0

^#Numbers in the Table were weighted to represent the entire U.S. non-institutionalized adults.

^†Two models were implemented: Model 1 compared the difference between all cancer survivors and non-cancer individuals (two groups), and Model 2 compared difference between recent survivors, long-term survivors, and non-cancer individuals (three groups).

^‡Raw ORs and differences without covariate adjustment.

^*p<0.05;

^**p<0.01,

^***p<0.001.